A recently-developed blood-based peripheral marker that can be used to identify autism-associated ileocolitis could help clinicians develop more effective, patient-specific strategies for symptom management.
Butyrate, also known as butyric acid, is an emerging treatment option for a wide range of health conditions, particularly gastrointestinal disorders and GI-associated neurological conditions like autism spectrum disorder (ASD).
Autism spectrum disorder (ASD) is a multifaceted neurological condition with a multitude of emotional, cognitive, behavioral, and physical symptoms that may vary in presentation amongst individuals.
The relationship between autism and food is inherently complex, but provides important opportunities for both prevention and treatment of this challenging condition.
As parents and clinicians seek to find symptom relief for children with autism spectrum disorder (ASD), complementary therapies are increasingly being used to enhance outcomes.
An increasingly detailed and interconnected body of scientific literature is establishing the connection between the pathology of autism spectrum disorder (ASD) and the gut microbiome.
Within the scientific and clinical communities, homeopathy has been a part of the conversation around autism spectrum disorder (ASD) treatment options for years, but evidence supporting its use remains slim.
Clarification of the connection between autism and gut bacteria is helping scientists, clinicians, parents, and patients better understand the complexities of autism-related symptoms and their potential causes.
As the body of research highlighting potential health benefits of butyric acid grows, both researchers and health practitioners are recommending bioavailable butyric acid supplements for patients with a wide variety of health conditions.
As alternative medicine enters the mainstream and nutraceuticals gain popularity, specialized bioavailability pharmacology is becoming paramount to delivering optimal therapeutic benefits to patients .